San Diego, CA -- (SBWIRE) -- 05/02/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Larimar Therapeutics, Inc.
San Diego, CA -- (SBWIRE) -- 03/02/2022 -- Larimar Therapeutics, Inc is under investigation over potential securities laws violations in connection with certain financial statements.
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Larimar Therapeutics, Inc. (“Larimar” or the “Company”) (NASDAQ: LRMR). Investors who purchased Larimar shares are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: www.bgandg.com/lrmr.
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Larimar Therapeutics, Inc. (“Larimar” or the “Company”) (NASDAQ: LRMR). Investors who purchased Larimar shares are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: www.bgandg.com/lrmr.
